BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21748802)

  • 1. Factors determining electrostatic fields in molecular dynamics simulations of the Ras/effector interface.
    Ensign DL; Webb LJ
    Proteins; 2011 Dec; 79(12):3511-24. PubMed ID: 21748802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vibrational Stark effect spectroscopy at the interface of Ras and Rap1A bound to the Ras binding domain of RalGDS reveals an electrostatic mechanism for protein-protein interaction.
    Stafford AJ; Ensign DL; Webb LJ
    J Phys Chem B; 2010 Nov; 114(46):15331-44. PubMed ID: 20964430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved electrostatic fields at the Ras-effector interface measured through vibrational Stark effect spectroscopy explain the difference in tilt angle in the Ras binding domains of Raf and RalGDS.
    Walker DM; Wang R; Webb LJ
    Phys Chem Chem Phys; 2014 Oct; 16(37):20047-60. PubMed ID: 25127074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vibrational Stark effect spectroscopy reveals complementary electrostatic fields created by protein-protein binding at the interface of Ras and Ral.
    Walker DM; Hayes EC; Webb LJ
    Phys Chem Chem Phys; 2013 Aug; 15(29):12241-52. PubMed ID: 23771025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of electrostatics in differential binding of RalGDS to Rap mutations E30D and K31E investigated by vibrational spectroscopy of thiocyanate probes.
    Ragain CM; Newberry RW; Ritchie AW; Webb LJ
    J Phys Chem B; 2012 Aug; 116(31):9326-36. PubMed ID: 22738401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrostatic effects of mutations of Ras glutamine 61 measured using vibrational spectroscopy of a thiocyanate probe.
    Stafford AJ; Walker DM; Webb LJ
    Biochemistry; 2012 Apr; 51(13):2757-67. PubMed ID: 22385209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-protein recognition: an experimental and computational study of the R89K mutation in Raf and its effect on Ras binding.
    Zeng J; Fridman M; Maruta H; Treutlein HR; Simonson T
    Protein Sci; 1999 Jan; 8(1):50-64. PubMed ID: 10210183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A detailed thermodynamic analysis of ras/effector complex interfaces.
    Kiel C; Serrano L; Herrmann C
    J Mol Biol; 2004 Jul; 340(5):1039-58. PubMed ID: 15236966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressure-induced local unfolding of the Ras binding domain of RalGDS.
    Inoue K; Yamada H; Akasaka K; Herrmann C; Kremer W; Maurer T; Döker R; Kalbitzer HR
    Nat Struct Biol; 2000 Jul; 7(7):547-50. PubMed ID: 10876238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure determination of the Ras-binding domain of the Ral-specific guanine nucleotide exchange factor Rlf.
    Esser D; Bauer B; Wolthuis RM; Wittinghofer A; Cool RH; Bayer P
    Biochemistry; 1998 Sep; 37(39):13453-62. PubMed ID: 9753431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrostatically optimized Ras-binding Ral guanine dissociation stimulator mutants increase the rate of association by stabilizing the encounter complex.
    Kiel C; Selzer T; Shaul Y; Schreiber G; Herrmann C
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9223-8. PubMed ID: 15197281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
    Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.
    Wolthuis RM; Bauer B; van 't Veer LJ; de Vries-Smits AM; Cool RH; Spaargaren M; Wittinghofer A; Burgering BM; Bos JL
    Oncogene; 1996 Jul; 13(2):353-62. PubMed ID: 8710374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.
    Ehrhardt GR; Korherr C; Wieler JS; Knaus M; Schrader JW
    Oncogene; 2001 Jan; 20(2):188-97. PubMed ID: 11313946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding free energies and free energy components from molecular dynamics and Poisson-Boltzmann calculations. Application to amino acid recognition by aspartyl-tRNA synthetase.
    Archontis G; Simonson T; Karplus M
    J Mol Biol; 2001 Feb; 306(2):307-27. PubMed ID: 11237602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the structure and mechanism of H-ras p21.
    Goody RS; Pai EF; Schlichting I; Rensland H; Scheidig A; Franken S; Wittinghofer A
    Philos Trans R Soc Lond B Biol Sci; 1992 Apr; 336(1276):3-10; discussion 10-1. PubMed ID: 1351293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effector loop and prenylation site of R-Ras are involved in the regulation of integrin function.
    Oertli B; Han J; Marte BM; Sethi T; Downward J; Ginsberg M; Hughes PE
    Oncogene; 2000 Oct; 19(43):4961-9. PubMed ID: 11042683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-mutant analysis of the interaction of Ras with the Ras-binding domain of RGL.
    Shirouzu M; Hashimoto K; Kikuchi A; Yokoyama S
    Biochemistry; 1999 Apr; 38(16):5103-10. PubMed ID: 10213614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMBINE analysis of the specificity of binding of Ras proteins to their effectors.
    Tomić S; Bertosa B; Wang T; Wade RC
    Proteins; 2007 May; 67(2):435-47. PubMed ID: 17295314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.